FDA Panel in Favor of TriClip for Tricuspid Regurgitation FDA Panel in Favor of TriClip for Tricuspid Regurgitation

An FDA advisory panel voted 13 to 1 that the benefits of Abbott ' s first-of-its-kind transcatheter system to treat tricuspid regurgitation outweigh any potential risks.Medscape Medical News

Source: Medscape Medical News Headlines - February 15, 2024 Category: Consumer Health News Tags: Cardiology Source Type: news